Breaking News Instant updates and real-time market news.

MRK

Merck

$54.90

-0.53 (-0.96%)

16:30
02/13/18
02/13
16:30
02/13/18
16:30

Merck discontinues APECS study

Merck announced that it will be stopping protocol 019, also known as the APECS study, a Phase 3 study evaluating verubecestat, an investigational small molecule inhibitor of the beta-site amyloid precursor protein cleaving enzyme 1, in people with prodromal Alzheimer's disease. The decision to stop the study follows a recommendation by the external Data Monitoring Committee, which assessed overall benefit/risk during a recent interim safety analysis. The eDMC concluded that it was unlikely that positive benefit/risk could be established if the trial continued. Data from the APECS study will be presented at an upcoming medical meeting. "We are disappointed with this outcome, especially given the lack of treatment options for patients suffering from Alzheimer's disease," said Dr. Roger M. Perlmutter, president, Merck Research Laboratories. "We are grateful to the patients and caregivers who participated in this study, and despite this outcome, Merck remains committed to developing novel therapies for the treatment of Alzheimer's and other neurodegenerative diseases."

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 04

    Apr

  • 23

    Apr

  • 23

    Oct

MRK Merck
$54.90

-0.53 (-0.96%)

01/17/18
BMOC
01/17/18
NO CHANGE
Target $72
BMOC
Outperform
Merck price target raised to $72 from $68 at BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Merck to $72 from $68, keeping his Outperform rating following a 6% move higher in the stock price yesterday. The analyst says he remains bullish based on a "meaningful upside for Keytruda" and better performance from supporting drug franchises such as Gardasil. Arfaei warns however that while Keytruda has solidified its lead in non-small cell lung cancer market, it remains the company's only major growth driver while immuno oncology becomes increasingly more competitive.
01/16/18
01/16/18
UPGRADE
Target $72

Buy
Merck upgraded on earlier than expected Keytruda trial success at SunTrust
As previously reported, SunTrust analyst John Boris upgraded Merck to Buy from Hold, stating that he had expected positive data from the Keynote-189 trial but that the positive results on Progression Free Survival and Overall Survival came earlier than expected. This timing should enable Merck to maintain its first-mover advantage in first-line non-squamous Non-Small Cell Lung Cancer, or NSCLC, in the U.S. and file in the EU, Boris tells investors. He raised his price target to $72 from $54 on Merck shares, which are up $4.09, or 7%, to $62.75 in morning trading.
01/16/18
RHCO
01/16/18
UPGRADE
RHCO
Buy
Merck upgraded to Buy from Hold at SunTrust
12/07/17
PIPR
12/07/17
NO CHANGE
PIPR
Roche lung cancer data underwhelming versus Merck's, says Piper Jaffray
Piper Jaffray analyst Richard Purkiss says that while Roche's (RHHBY) IMpower150 data are strong and suggesting a likelihood that the combination of Tecentriq with Avastin and chemo will be approved in non-small cell lung cancer, the data also appear underwhelming compared to Merck's (MRK) KN-21G trial data. The analyst does expect Tecentriq approval in lung cancer next year and reiterates an Overweight rating on Roche. Whether KN-021G represents the "high water mark" for efficacy can only be answered following full presentation of the remaining pivotal Phase 3 trials in this setting, and until then confusion is likely to remain, Purkiss tells investors in a research note. Merck in premarket trading is up 85c to $55.20 while Roche is down 93c to $30.40.

TODAY'S FREE FLY STORIES

WGO

Winnebago

$45.35

4.95 (12.25%)

, THO

Thor Industries

$104.40

6.09 (6.19%)

12:52
06/20/18
06/20
12:52
06/20/18
12:52
Hot Stocks
Winnebago results spark buying in RV names »

Shares of recreational…

WGO

Winnebago

$45.35

4.95 (12.25%)

THO

Thor Industries

$104.40

6.09 (6.19%)

REVG

REV Group

$16.08

0.25 (1.58%)

PII

Polaris Industries

$124.94

0.34 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

BIG

Big Lots

$41.16

0.39 (0.96%)

12:50
06/20/18
06/20
12:50
06/20/18
12:50
Options
Big lots in Big Lots »

Big lots in Big Lots. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$55.29

3.26 (6.27%)

12:40
06/20/18
06/20
12:40
06/20/18
12:40
Options
Timely sweep buyer of Papa John's weeklys »

Timely sweep buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:40
06/20/18
06/20
12:40
06/20/18
12:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

AAL

American Airlines

$42.29

0.78 (1.88%)

12:37
06/20/18
06/20
12:37
06/20/18
12:37
Hot Stocks
American asks government not to use planes for separated children »

American released a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

AEP

American Electric

$66.87

(0.00%)

12:30
06/20/18
06/20
12:30
06/20/18
12:30
Hot Stocks
SWEPCO says LPSC approves proposed Wind Catcher Energy Connection project »

Southwestern Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$43.44

-0.16 (-0.37%)

12:25
06/20/18
06/20
12:25
06/20/18
12:25
Conference/Events
The Executives' Club of Chicago to hold a meeting »

The Executives Club of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

SPY

SPDR S&P 500 ETF Trust

$276.40

0.92 (0.33%)

12:20
06/20/18
06/20
12:20
06/20/18
12:20
Options
Aggressive call spreads in SPYders »

Aggressive call spreads…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$202.58

5.12 (2.59%)

12:17
06/20/18
06/20
12:17
06/20/18
12:17
Hot Stocks
Facebook tests 'subscription groups' for administrators »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
06/20/18
06/20
12:17
06/20/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
06/20/18
06/20
12:16
06/20/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$60.04

2.91 (5.09%)

12:15
06/20/18
06/20
12:15
06/20/18
12:15
Options
Signet Jewelers put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$276.27

0.79 (0.29%)

12:14
06/20/18
06/20
12:14
06/20/18
12:14
Technical Analysis
Technical Take: SPDR S&P 500 ETF round-trips to session highs at midday »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$276.27

0.79 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$44.08

4.04 (10.09%)

, CLVS

Clovis

$47.48

1.74 (3.80%)

12:11
06/20/18
06/20
12:11
06/20/18
12:11
Recommendations
Tesaro, Clovis analyst commentary  »

SunTrust analysis yields…

TSRO

Tesaro

$44.08

4.04 (10.09%)

CLVS

Clovis

$47.48

1.74 (3.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATUS

Altice USA

$17.52

0.42 (2.46%)

12:09
06/20/18
06/20
12:09
06/20/18
12:09
Hot Stocks
Altice says U.S .mobile service available in 2019,names Jean-Charles Nicolas SVP »

Altice USA announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOXA

21st Century Fox

$47.86

3.15 (7.05%)

, DIS

Disney

$106.00

-0.2 (-0.19%)

12:01
06/20/18
06/20
12:01
06/20/18
12:01
General news
On The Fly: Top stock stories at midday »

Stocks opened higher as…

FOXA

21st Century Fox

$47.86

3.15 (7.05%)

DIS

Disney

$106.00

-0.2 (-0.19%)

CMCSA

Comcast

$32.77

-0.04 (-0.12%)

GE

General Electric

$12.86

-0.105 (-0.81%)

WBA

Walgreens Boots Alliance

$67.72

3.11 (4.81%)

SBUX

Starbucks

$52.40

-5.03 (-8.76%)

ORCL

Oracle

$42.86

-3.43 (-7.41%)

FDX

FedEx

$253.85

-4.495 (-1.74%)

AMZN

Amazon.com

$1,755.30

19.56 (1.13%)

JPM

JPMorgan

$108.08

0.5 (0.46%)

BRK.A

Berkshire Hathaway

$285,450.00

-810 (-0.28%)

I

Intelsat

$19.52

3.46 (21.54%)

SYNA

Synaptics

$54.39

5.58 (11.43%)

DLGNF

Dialog Semiconductor

$0.00

(0.00%)

FOX

21st Century Fox

$47.24

2.96 (6.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 20

    Jun

  • 22

    Jun

  • 28

    Jun

  • 09

    Jul

  • 10

    Jul

  • 12

    Jul

  • 13

    Jul

  • 20

    Sep

  • 21

    Sep

  • 12

    Oct

T

AT&T

$32.02

-0.37 (-1.14%)

12:01
06/20/18
06/20
12:01
06/20/18
12:01
Periodicals
AT&T plans to acquire all of Otter Media, Recode reports »

AT&T intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHI

Sinopec Shanghai

$63.23

-4.37 (-6.46%)

12:00
06/20/18
06/20
12:00
06/20/18
12:00
Hot Stocks
Sinopec Shanghai falls -6.4% »

Sinopec Shanghai is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$42.91

-3.38 (-7.30%)

12:00
06/20/18
06/20
12:00
06/20/18
12:00
Hot Stocks
Oracle falls -7.3% »

Oracle is down -7.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEW

Puxin Limited

$26.90

-2.8 (-9.43%)

12:00
06/20/18
06/20
12:00
06/20/18
12:00
Hot Stocks
Puxin Limited falls -10.9% »

Puxin Limited is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATU

Actuant

$28.40

2.45 (9.44%)

12:00
06/20/18
06/20
12:00
06/20/18
12:00
Hot Stocks
Actuant rises 9.7% »

Actuant is up 9.7%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 27

    Jun

WGO

Winnebago

$45.75

5.35 (13.24%)

12:00
06/20/18
06/20
12:00
06/20/18
12:00
Hot Stocks
Winnebago rises 13.6% »

Winnebago is up 13.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

HAL

Halliburton

$45.85

-0.25 (-0.54%)

12:00
06/20/18
06/20
12:00
06/20/18
12:00
Options
Second day of interest in Halliburton Aug 50 calls »

Second day of interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

I

Intelsat

$19.50

3.44 (21.42%)

12:00
06/20/18
06/20
12:00
06/20/18
12:00
Hot Stocks
Intelsat rises 21.4% »

Intelsat is up 21.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$54.40

0.625 (1.16%)

11:57
06/20/18
06/20
11:57
06/20/18
11:57
Conference/Events
National Press Club to host a luncheon meeting »

Luncheon Meeting with Ed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.